Showing results (271-280 of 330) with videos related to
Sort By:
Pageof 33
Acta Neuropsychiatrica|October 30, 2015
Increased serum levels of serine enantiomers in patients with depressionKenji Hashimoto, Taisuke Yoshida, Masatomo Ishikawa, et al.Neuroscience Letters|June 5, 2003
Two clusters of serum midkine levels in drug-naive patients with schizophreniaEiji Shimizu, Kenji Hashimoto, Ragaa H M Salama, et al.Biological Psychiatry|May 19, 2007
Decreased serum levels of platelet-endothelial adhesion molecule (PECAM-1) in subjects with high-functioning autism: a negative correlation with head circumference at birthKenji J Tsuchiya, Kenji Hashimoto, Yasuhide Iwata, et al.Neuroscience Letters|April 17, 2009
An association study of monoamine oxidase A (MAOA) gene polymorphism in methamphetamine psychosisKazuhiko Nakamura, Yoshimoto Sekine, Noriyoshi Takei, et al.Psychiatry and Clinical Neurosciences|November 29, 2016
Altered serum level of matrix metalloproteinase-9 and its association with decision-making in eating disordersJunko Matsumoto, Yoshiyuki Hirano, Kenji Hashimoto, et al.Journal of Psychiatric Research|April 18, 2021
Oxytocin system dysfunction in patients with treatment-resistant schizophrenia: Alterations of blood oxytocin levels and effect of a genetic variant of OXTRYusuke Nakata, Nobuhisa Kanahara, Atsushi Kimura, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 21, 2011
Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophreniaTomihisa Niitsu, Yukihiko Shirayama, Daisuke Matsuzawa, et al.Current Neuropharmacology|September 3, 2011
Lack of association between prokineticin 2 gene and Japanese methamphetamine dependenceTaro Kishi, Tsuyoshi Kitajima, Tomoko Tsunoka, et al.Neuroscience Letters|February 19, 2008
Reduced CYP2D6 activity is a negative risk factor for methamphetamine dependenceKyohei Otani, Hiroshi Ujike, Ayumu Sakai, et al.BMC Research Notes|October 9, 2016
A feasibility study of the clinical effectiveness and cost-effectiveness of individual cognitive behavioral therapy for panic disorder in a Japanese clinical setting: an uncontrolled pilot studyYoichi Seki, Shinobu Nagata, Takayuki Shibuya, et al.Pageof 33